| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CTO
1 company
Gordon Roman serves as a CTO at CVAT. Across recent SEC filings that breaks down to 0 buys and 1 sell. Those positions are worth an estimated $588K at current prices.
The biggest single holding is CVAT (~$588K) as CTO. The recent filings there lean toward selling, a net 35,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 26, 2013 | CVAT Cavitation Technologies, Inc. | CTO | Sell | 35,000 | $0.12 | $4,189.50 | -0.2% |